Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 318,158 shares at $28.90 ($8.5M) on 2024-02-08, disclosed to the SEC on 2024-02-08.
Scheduled sale ($8.5M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.75 | 49,079 | $1.3M | 14.9% |
| 2 | $25.75 | 49,079 | $1.3M | 14.9% |
| 3 | $25.95 | 60,000 | $1.6M | 18.3% |
| 4 | $26.95 | 80,000 | $2.2M | 25.4% |
| 5 | $27.45 | 40,000 | $1.1M | 12.9% |
| 6 | $28.90 | 40,000 |
| $1.2M |
| 13.6% |
| Total | $26.70 avg | 318,158 | $8.5M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |